+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists



The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists



Ophthalmic Epidemiology 13(4): 263-274



To estimate the annual cost associated with the management of dry eye patients by ophthalmologists in France, Germany, Italy, Spain, Sweden, and the United Kingdom (UK) from the perspective of the healthcare systems in the respective countries. Published epidemiological and healthcare resource use data attributable to dry eye syndrome was supplemented with information obtained from interviewing ophthalmologists in the six countries. The estimated prevalence of dry eye syndrome among patients reporting to ophthalmologists was less than 0.1% in all six countries. The total annual healthcare cost of 1,000 dry eye syndrome sufferers managed by ophthalmologists ranged from 0.27 million US dollars (95% CI: 0.20 US dollars; 0.38 million US dollars) in France to 1.10 million US dollars (95% CI: 0.70 US dollars; 1.50 million US dollars) in the UK. A large proportion of dry eye patients either self-treat or are managed by their general practitioner. Hence, our analysis reflects the prevalence and costs of those patients severe enough to warrant treatment by an ophthalmologist. Given the limitations of the available economic evidence and our data sources, dry eye syndrome does not appear to impose a direct burden to the health care expenditure in the countries investigated. However, given that many dry eye sufferers self-treat with over-the-counter artificial tears and other medications, data which our study did not capture, the true societal costs of dry eye syndrome, borne by both patient and government, are likely to be higher.

(PDF emailed within 0-6 h: $19.90)

Accession: 050570718

Download citation: RISBibTeXText

PMID: 16877285

DOI: 10.1080/09286580600801044


Related references

Cost of diabetic foot in France, Spain, Italy, Germany and United Kingdom: A systematic review. Annales D'endocrinologie: -, 2018

Value of Life and Cost of Pre-Mature Deaths With The Perspective of Productivity As Net Tax Revenue: A Comparison in France, Germany, Italy, Spain, United Kingdom. Value in Health 17(7): A424-A424, 2014

Cost of treatment for acute opportunistic disease episodes for AIDS patients in Germany, France, Italy, United Kingdom and Switzerland. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 919, 1993

Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom. Journal of Headache and Pain 19(1): 82-82, 2018

Effectiveness and cost of antiviral treatment with zalcitabine in combination with zidovudine for AIDS patients in Germany, France, Italy, United Kingdom and Switzerland. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 936, 1993

Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom. International Journal of Women's Health 5(): 261-269, 2013

Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. Journal of Hepatology: -, 2018

Coated groundwood paper from Austria, Belgium, Finland, France, Germany, Italy, The Netherlands, Sweden, and the United Kingdom. 1991

Off-Label Use of Intravenous Immunoglogulins (IVIGS): Funding Mechanisms in France, Germany, Italy, Spain and the United Kingdom (EU5). Value in Health 18(7): A552-A552, 2015

Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness study. Clinicoeconomics and Outcomes Research 7(): 163-171, 2015

Maternal Screening And Treatment For Group B Streptococcus (GBS) Are Associated With Non-Adherence To Guidelines, False-Negative Results And High Management Costs In The United Kingdom, Italy, France, Spain And Germany. Value in Health 20(9): A797-A798, 2017

Market development survey on meat and meat products in United Kingdom, Western Germany, Spain, Greece, Italy and France, Spring 1957. 1957

Experts estimates of standard clinical treatment of AIDS patients in Germany, France, Italy, United Kingdom and Switzerland. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 936, 1993

Special issue: Health care technology and its assessment in eight countries: Australia, Canada, France, Germany, Netherlands, Sweden, United Kingdom, United States. Health Policy 30(1-3): 1-421, 1994

International pharmaceutical spending controls: France, Germany, Sweden, and the United Kingdom. Health Care Financing Review 15(3): 127-140, 1995